High-dose therapy and autologous hematopoietic stem-cell transplantation does not increase the risk of second neoplasms for patients with Hodgkin's lymphoma: a comparison of conventional therapy alone versus conventional therapy followed by autologo (Q81308196)
Jump to navigation
Jump to search
scientific article published on 03 October 2005
Language | Label | Description | Also known as |
---|---|---|---|
English | High-dose therapy and autologous hematopoietic stem-cell transplantation does not increase the risk of second neoplasms for patients with Hodgkin's lymphoma: a comparison of conventional therapy alone versus conventional therapy followed by autologo |
scientific article published on 03 October 2005 |
Statements
High-dose therapy and autologous hematopoietic stem-cell transplantation does not increase the risk of second neoplasms for patients with Hodgkin's lymphoma: a comparison of conventional therapy alone versus conventional therapy followed by autologous hematopoietic stem-cell transplantation (English)
Randy D Gascoyne
Joseph M Connors
Nicholas J Voss
Cynthia L Toze
Donna E Hogge
Stephen H Nantel
Donna L Forrest
Thomas J Nevill
Michael J Barnett
John D Shepherd
Heather J Sutherland
Clayton A Smith